Blunt Approach: Fecal Transplants

Emily BurkeThe WEEKLY

FECAL TRANSPLANTS: A BLUNT APPROACH The premise behind microbiome-based therapeutics is straightforward: identify differences in the microbiome of people suffering from a particular disease, and then try to make the sick person’s microbiome more like the healthy person’s. Rankings from the most radical (or just plain stomach-turning) to the most standard, here is a snapshot of microbiome-based therapeutics: Fecal transplants … Read More

Science Geeks Rock!

Emily BurkeThe WEEKLY

THE SCIENCE DRIVING BIOTECH Next week, BioTech Primer will be participating the BIO 2014 Annual International Convention in San Diego, CA. The event draws thousands and, as in years past, BioTech Primer will be headlining a few events. Join us and learn! On Monday, June 23, I will be teaching an all-day class called “The Science Driving Biotech.” What can … Read More

Scabbing Now A “Walk In The Park” For Hemophilia A Sufferers

Emily BurkeThe WEEKLY

SCABBING NOW A WALK IN THE PARK FOR HEMOPHILIA A SUFFERERS Imagine tripping over your feet, face-planting on a sidewalk. You are in shorts, your knees scrape, and you are bloody. You clean it off, and soon you are the proud owner of some new scabs. Life goes on. Let’s say you are the one of the 5,000 men with … Read More

Saved By Screening

Emily BurkeThe WEEKLY

NEW COMPANION DIAGNOSTIC APPROVAL Colorectal cancer is the third most common cancer found in both men and women in the U.S., and is the second leading cause of cancer deaths. Approximately 1.2 million cases of colorectal cancer are expected to occur globally. Just last week, the FDA approved Qiagen’s Therascreen KRAS companion diagnostic to identify colorectal cancer patients most likely … Read More